Personalized Cancer Vaccine Boosts Recurrence-Free Survival in Melanoma

(MedPage Today) -- ORLANDO -- Adding a personalized cancer vaccine to anti-PD-1 immunotherapy for resectable melanoma led to a 44% improvement in recurrence-free survival (RFS) versus immunotherapy alone, according to a study reported here....
Source: MedPage Today Dermatology - Category: Dermatology Source Type: news